ADP vs DMAC · P/E 20, rev $21.95B vs $157.4M cap
Automatic Data Processing Inc (ADP) versus DiaMedica Therapeutics Inc (DMAC) — a side-by-side from cached financials, not a winner call.
Automatic Data Processing Inc (ADP) is a software - application company listed on NASDAQ.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Latest reported ADP revenue for 2026-06-30 was $21.95B. Net income was $4.41B. Revenue was up 6.7% from 2025-06-30 to 2026-06-30. ADP currently screens at market cap $87.45B and trailing P/E 20.4.
DMAC does not have a complete income-statement cache yet.
ADP currently screens at market cap $87.45B and trailing P/E 20.4. DMAC currently screens at market cap $157.4M.
Not investment advice. Open the ADP and DMAC stock pages for the full models.
Not investment advice.